Company characteristics
Assessed report publication year |
|
Financial year end |
31/12/23 |
Sector |
Health Care |
Head office |
United Kingdom |
Primary listing |
London Stock Exchange |
GBP market cap |
164,317,238,356 |
Net profit margin |
13.01% |
CEO tenure |
11.2 years |
Employee count |
86,400 |
FRF draft assessment response |
 |
Reward scrutiny
Living wage accredited |
 |
Living wage (calculation for operating regions) |
 |
Living hours accredited |
 |
Tax reporting (GRI 207) |
 |
Remuneration policies
Remuneration committee 100% independent |
 |
Remuneration committee discretion applied |
 |
Director from workforce |
 |
Trade union relations (disclosure) |
 |
Worker consultation on top pay (disclosure) |
 |
80%+ shareholder support on pay |
 |
Reward outcomes
CEO total pay (GBP) |
16,853,000 |
CEO total pay change |
9.98% |
CEO pay ratio (to median employee) |
182:1 |
Percentage point increase in maximum variable remuneration |
150% |
Pension award parity between CEO and wider workforce |
 |
Pay of the next highest exec compared to CEO |
26.16% |
Gender pay gap (mean data) |
7.90% |
Gender pay (women % in top quartile) |
42.70% |
Ethnicity pay gap (disclosure) |
 |
Total dividend (USD) |
4,495,471,615 |